Biologics

Sana shares 14-month data for ‘functional cure’ diabetes program

Sana is evaluating a donor-derived primary islet cell therapy designed to serve as a Type 1 diabetes treatment that doesn’t require immunosuppression.

Gabrielle Masson Mar 13, 2026 10:55am

Ultragenyx gene therapy lessens ammonia levels in ph. 3

Mar 12, 2026 11:33am

Regenxbio gene therapy passes interim test as pivotal data loom

Mar 12, 2026 5:49am

Large-scale gene editing tool could power novel genetic meds

Mar 11, 2026 12:00pm

FDA reconsidering Capricor’s snubbed DMD cell therapy

Mar 10, 2026 11:14am

Senior FDA official fires back at uniQure amid controversy

Mar 5, 2026 3:33pm